Invention Grant
- Patent Title: Antibody purification and purity monitoring
-
Application No.: US15331241Application Date: 2016-10-21
-
Publication No.: US10533045B2Publication Date: 2020-01-14
- Inventor: Daniel S. Allison , Steven D. Davin , Hoa Binh Do , Leon F. Garcia-Martinez , Geoffrey F. Lee , Ethan W. Ojala , Mark Young , John A. Latham
- Applicant: ALDERBIO HOLDINGS LLC
- Applicant Address: US WA Bothell
- Assignee: ALDER BIOPHARMACEUTICALS, INC.
- Current Assignee: ALDER BIOPHARMACEUTICALS, INC.
- Current Assignee Address: US WA Bothell
- Agency: Baker, Donelson, Bearman Caldwell & Berkowitz PC
- Agent Robin L. Teskin
- Main IPC: C07K16/18
- IPC: C07K16/18 ; B01D15/32 ; B01D15/38 ; C07K1/16 ; C07K1/22 ; G01N33/68 ; C07K16/06 ; B01D15/42 ; C07K1/20 ; C07K1/34 ; C07K1/36

Abstract:
Processes for producing and purifying recombinant proteins are disclosed. In particular, the present disclosure provides processes of producing and purifying multi-subunit proteins expressed in yeast or filamentous fungal cells. The production and/or purification of such proteins are monitored for impurities, preferably using lectin binding assays, such that one or more process parameters may be adjusted to maximize the amount of desired recombinant protein and minimize the amount of glycosylated impurities. The processes can also be monitored for other undesired product-associated impurities, such as aggregates and nucleic acids. In exemplary embodiments, the recombinant proteins are multi-subunit proteins, such as antibodies, the host cell is a yeast, such as Pichia pastoris, and the glycosylated impurity is a glycovariant of the desired recombinant polypeptide, such as an N-linked and/or O-linked glycovariant.
Public/Granted literature
- US20170137500A1 ANTIBODY PURIFICATION AND PURITY MONITORING Public/Granted day:2017-05-18
Information query